Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia

被引:0
作者
Aydin, Kaniye [1 ]
Gurkan, Emel [2 ]
机构
[1] Cukurova Univ, Fac Med, Dept Internal Med, Dept Intens Care, Adana, Turkey
[2] Dept Hematol, Adana, Turkey
来源
CUKUROVA MEDICAL JOURNAL | 2022年 / 47卷 / 02期
关键词
Immune thrombocytopenia; intravenous immunoglobulin; methylprednisolone; conventional prednisolone; treatment; INTERNATIONAL CONSENSUS REPORT; PURPURA; DEXAMETHASONE; EPIDEMIOLOGY; MANAGEMENT; CHILDREN;
D O I
10.17826/cumj.1085840
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We aimed to compare the efficacy of high-dose methylprednisolone (HDP) with intravenous immunoglobulin (IVIG) and conventional prednisolone (CDP) as a first-line therapy in adult patients with immune thrombocytopenia (ITP). Materials and Methods: This retrospective study included 140 adult patients with either previously untreated newly diagnosed ITP (n=51) or persistent or chronic ITP (n=22/n=67)) with episodes. Patients with a platelet count <30x10(9)/L or <50x10(9)/L with a clinically significant bleeding were treated either by CDP therapy (1mg/kg/d until response) or HDP (20 mg/kg/d for 3 d) or IVIG (1g/kg/d for 2 d). The patients in all groups continued treatment with oral prednisolone (1 mg/kg/d) until their platelet counts stabilized. After therapy, patients' responses and clinical courses were evaluated. Results: The initial platelet counts were similar in all groups. HDP was given to 92 patients (65.7%), IVIG to 32 (22.8%), and CDP to 16 (11.4%). Although the HDP group showed a first response sooner than the IVIG and CDP groups, the median platelet count at first response was similar in all groups. Long-term remission was greater in the HDP group (57.6%) than in the IVIG (37.5%) and CDP (25.0%) groups, and their respective recurrence rates were 62.8%, 81.3% and 88.9%. Conclusion: Our results indicate that HDP's relative effectiveness, low cost, and convenience of use continue to recommend it as a first-line therapy for adult patients with ITP.
引用
收藏
页码:715 / 721
页数:7
相关论文
共 50 条
  • [21] Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting
    Xu, Jin
    Zhang, Xinhui
    Feng, Shanglong
    Zhao, Na
    Hu, Xin
    Cheng, Yaxin
    Wu, Yue
    Zhou, Li
    Tong, Juan
    Zheng, Changcheng
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (04)
  • [22] Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial
    Mazzucconi, Maria Gabriella
    Rodeghiero, Francesco
    Avvisati, Giuseppe
    De Stefano, Valerio
    Gugliotta, Luigi
    Ruggeri, Marco
    Vianelli, Nicola
    Fazi, Paola
    Paoloni, Francesca
    Sargentini, Valeria
    Baldacci, Erminia
    Ferretti, Antonietta
    Martino, Bruno
    Vincelli, Iolanda Donatella
    Carli, Giuseppe
    Fortuna, Stefania
    Di Ianni, Mauro
    Ranalli, Paola
    Palandri, Francesca
    Polverelli, Nicola
    Lugli, Elisabetta
    Rivolti, Elena
    Patriarca, Andrea
    Rago, Angela
    D'Adda, Mariella
    Gentile, Massimo
    Siragusa, Sergio
    Sibilla, Silvia
    Carella, Angelo Michele
    Rossi, Elena
    Battistini, Roberta
    Zaja, Francesco
    Bocchia, Monica
    Di Renzo, Nicola
    Musto, Pellegrino
    Crugnola, Monica
    Giuffrida, Anna Chiara
    Krampera, Mauro
    Tafuri, Agostino
    Santoro, Cristina
    BLOOD ADVANCES, 2024, 8 (06) : 1529 - 1540
  • [23] All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial
    Huang, Qiu-Sha
    Liu, Yi
    Wang, Jing-Bo
    Peng, Jun
    Hou, Ming
    Liu, Hui
    Feng, Ru
    Wang, Jing-Wen
    Xu, Lan-Ping
    Wang, Yang
    Huang, Xiao-Jun
    Zhang, Xiao-Hui
    LANCET HAEMATOLOGY, 2021, 8 (10): : E688 - E699
  • [24] Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura
    Oner, AF
    Bay, A
    Kuru, M
    Uner, A
    Arslan, S
    Caksen, H
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (04) : 489 - 492
  • [25] Relationships of platelet glycoprotein specific antibody with therapeutic efficacy of short-term high-dose dexamethasone and bleeding score in the newly diagnosed adult patients with primary immune thrombocytopenia
    Song, Mengting
    Wang, Xiujuan
    Sun, Mingling
    Wang, Lei
    Wang, Xinyou
    Liu, Ying
    Fan, Wenxia
    Li, Qinzhi
    Guo, Xinhong
    HEMATOLOGY, 2023, 28 (01)
  • [26] High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study
    Jie Ma
    Lingling Fu
    Zhengping Chen
    Hao Gu
    Jingyao Ma
    Runhui Wu
    International Journal of Hematology, 2020, 112 : 773 - 779
  • [27] Efficacy and safety of romiplostim in adult Iraqi patients with refractory immune thrombocytopenia
    Jumaa, Ali
    Saleh, Tareq
    Khalaf, Asaad
    Abbas, Mohammed
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 92 - 96
  • [28] Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia
    Cura, Musa
    Koc, Ahmet
    Aksoy, Nurten
    Ozdemir, Zeynep Canan
    BLOOD RESEARCH, 2016, 51 (04) : 261 - 267
  • [29] Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients
    Wandinger, KP
    Wessel, K
    Trillenberg, P
    Heindl, N
    Kirchner, H
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (06): : 359 - 365
  • [30] High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
    Wei, Yu
    Ji, Xue-bin
    Wang, Ya-wen
    Wang, Jing-xia
    Yang, En-qin
    Wang, Zheng-cheng
    Sang, Yu-qi
    Bi, Zuo-mu
    Ren, Cui-ai
    Zhou, Fang
    Liu, Guo-qiang
    Peng, Jun
    Hou, Ming
    BLOOD, 2016, 127 (03) : 296 - 302